Adrenocortical carcinoma screening: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
(4 intermediate revisions by one other user not shown) | |||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Adrenocortical carcinoma}} | {{Adrenocortical carcinoma}} | ||
{{CMG}}; {{AE}} {{AAM}} {{MAD}} | |||
==Overview== | |||
Screening is not recommended for adrenocortical carcinoma. | |||
==Screening== | |||
Screening is not recommended for adrenocortical carcinoma. | |||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} | ||
[[Category:Disease]] | [[Category:Disease]] | ||
[[Category:Pathology]] | [[Category:Pathology]] |
Latest revision as of 16:23, 25 September 2017
Adrenocortical carcinoma Microchapters |
Differentiating Adrenocortical carcinoma from other Diseases |
---|
Diagnosis |
Treatment |
Case Study |
Adrenocortical carcinoma screening On the Web |
American Roentgen Ray Society Images of Adrenocortical carcinoma screening |
Risk calculators and risk factors for Adrenocortical carcinoma screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ahmad Al Maradni, M.D. [2] Mohammed Abdelwahed M.D[3]
Overview
Screening is not recommended for adrenocortical carcinoma.
Screening
Screening is not recommended for adrenocortical carcinoma.